Keyphrases
Acute Myeloid Leukemia
38%
Acute Pancreatitis
30%
Acute Recurrent Pancreatitis
32%
Adipose Triglyceride Lipase
34%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
58%
Approved Drugs
7%
Autologous Transplantation
11%
Azacitidine
8%
Bile Salts
8%
Biotechnology Firms
6%
Carboxylesterase 1 (CES1)
17%
Cell Adhesion
11%
Cell Behavior
6%
Chemotherapy
12%
Chronic Pancreatitis
69%
Clinical Trials
6%
Colipase
40%
Complementary DNA (cDNA)
10%
Complete Remission
11%
Conditioning Regimen
6%
Confidence Interval
19%
Cyclophosphamide
6%
Cytarabine
11%
Decitabine
16%
Diabetes
13%
Dietary Fat
9%
Diffuse Large B-cell Lymphoma (DLBCL)
24%
Drug Development
7%
Drug Discovery
6%
E-cadherin
9%
EphA2
61%
EphA2 Receptor
9%
Epithelial Cells
7%
Etiology
8%
Fat Digestion
11%
FDA-approved Drugs
28%
Follicular Lymphoma
10%
Gene Perturbation
8%
Graft-versus-host Disease (GvHD)
7%
Granulocyte Colony-stimulating Factor (G-CSF)
15%
Hazard Ratio
8%
Hematopoietic Cell Transplantation
7%
Hodgkin Lymphoma
9%
Infectious Diseases
11%
INSPPIRE
28%
Integrin
9%
Interleukin-15 (IL-15)
7%
Lenalidomide
10%
Leukemia
9%
Leukemia Patients
6%
Lipase
33%
Lipase Activity
7%
Lipase Gene
7%
Lipolysis
6%
Lipoprotein-associated Phospholipase A2 (Lp-PLA2)
30%
Lymphoma Patients
15%
Malignant Cells
7%
Mantle Cell Lymphoma
15%
Misfolding
6%
Monoclonal Antibody
7%
Myeloablative Conditioning
6%
Myelodysplastic Syndrome
22%
Natural Killer Cells
11%
New Drugs
6%
New Medicines
11%
New Molecular Entity
29%
Older Patients
10%
Oncology
6%
Ovarian Cancer
8%
Overall Response Rate
7%
Overall Survival
19%
Overexpression
16%
Pancreas
13%
Pancreatic Cancer
7%
Pancreatic Lipase
32%
Pancreatitis
28%
Pediatric
25%
Pediatric Pancreatitis
21%
Pediatric Patients
6%
Pharmaceutical Companies
6%
Pharmaceutical Industry
6%
Phase I Study
8%
Phase II Study
15%
Plerixafor
14%
Porcine Pancreatic Lipase
16%
Progression-free Survival
12%
Reduced-intensity Conditioning
6%
Relapsed Lymphoma
10%
Relapsed or Refractory
22%
Relapsed or Refractory Acute Myeloid Leukemia
9%
Risk Factors
14%
Rituximab
17%
Stem Cell Mobilization
7%
Stem Cells
8%
Triglycerides
10%
Tumor
9%
Tumor Cells
12%
Tyrosine Kinase
19%
Tyrosine Phosphorylation
8%
U.S. Food
11%
Medicine and Dentistry
Acute Myeloid Leukemia
31%
Acute Pancreatitis
28%
Allogeneic Stem Cell Transplantation
7%
Autologous Stem Cell Transplantation
7%
Autotransplantation
8%
Azacitidine
7%
Bendamustine
5%
Biological Product
5%
Cell Therapy
5%
Cell Transplantation
27%
Chemokine Receptor CXCR4 Antagonist
5%
Chemotherapy
13%
Chronic Pancreatitis
59%
Classical Hodgkin Lymphoma
7%
Clinical Trial
8%
Cytarabine
6%
Cytotoxic T-Cell
8%
Cytotoxicity
6%
Decitabine
11%
Diabetes
14%
Diffuse Large B-Cell Lymphoma
19%
Disease
28%
Ephrin Receptor A2
6%
Follicular Lymphoma
5%
Granulocyte Colony Stimulating Factor
8%
Hazard Ratio
6%
Hematopoietic Cell
32%
Hematopoietic Stem Cell Transplantation
7%
Hodgkin's Lymphoma
10%
Infection
17%
Lenalidomide
7%
Leukemia
8%
Malignant Neoplasm
13%
Mantle Cell Lymphoma
13%
Medicine
13%
Monoclonal Antibody
5%
Myelodysplastic Syndrome
12%
Natural Killer Cell
10%
Neoplasm
18%
Oncology
11%
Orphan
6%
Ovarian Cancer
10%
Overall Survival
21%
Pancreas Cancer
6%
Pancreatitis
39%
Pediatrics
42%
Plerixafor
13%
Progression Free Survival
9%
Prostatic Intraepithelial Neoplasia
5%
Protein Tyrosine Kinase
12%
Rituximab
13%
Stem Cell
7%
Stem Cell Mobilization
5%
T Cell
6%
Transplantation
20%
Triacylglycerol Lipase
20%
Tumor Cell
7%
Tumor Progression
5%
Biochemistry, Genetics and Molecular Biology
Amino Acids
6%
B Cell
10%
C-Terminus
6%
Cadherin
11%
Cancer Cell
9%
Cell Adhesion
8%
Cell Function
6%
Colipase
36%
Copurification
8%
Dietary Fat
6%
Disease Burden
5%
Enzyme
5%
Gene Mutation
5%
Genetics
5%
Integrin
5%
Kinase
8%
Ligand Binding
8%
Messenger RNA
13%
Micelle
5%
Mouse Model
5%
Myeloid
7%
Overall Survival
5%
Pancreatic Lipase
100%
Phosphotransferase
8%
Polysaccharide
5%
Protease
6%
Protein Misfolding
5%
Proteotoxicity
5%
Receptor Tyrosine Kinase
27%
Secretion (Process)
7%
Signal Transduction
9%
T Cell
6%
Triacylglycerol Lipase
100%
Triglyceride
10%
Triglyceride Lipase
30%
Tumor Progression
7%
Tyrosine
10%
Tyrosine Kinase
11%
Tyrosine Phosphorylation
10%
Variable Number Tandem Repeat
6%